Foresite Capital Management II as of March 31, 2015
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 16 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zafgen | 25.0 | $38M | 3.5M | 10.68 | |
| Orexigen Therapeutics | 22.0 | $33M | 4.2M | 7.83 | |
| Epizyme | 9.5 | $14M | 755k | 18.78 | |
| Auspex Pharmaceuticals | 5.0 | $7.5M | 75k | 100.27 | |
| Regulus Therapeutics | 4.9 | $7.3M | 430k | 16.94 | |
| Aerie Pharmaceuticals | 4.4 | $6.6M | 210k | 31.34 | |
| Nexvet Biopharma Pub Ltd Co ord | 3.8 | $5.7M | 708k | 8.03 | |
| Quotient | 3.7 | $5.6M | 327k | 17.00 | |
| Juno Therapeutics | 3.7 | $5.6M | 92k | 60.66 | |
| Scynexis | 3.7 | $5.5M | 663k | 8.30 | |
| BioDelivery Sciences International | 3.1 | $4.7M | 448k | 10.50 | |
| Alder Biopharmaceuticals | 3.0 | $4.5M | 157k | 28.86 | |
| Agile Therapeutics | 2.8 | $4.3M | 459k | 9.27 | |
| T2 Biosystems | 2.4 | $3.6M | 233k | 15.52 | |
| Sangamo Biosciences (SGMO) | 1.7 | $2.6M | 165k | 15.68 | |
| Ignyta | 1.2 | $1.8M | 185k | 9.95 |
